Geldanamycin, an inhibitor of Hsp90, sensitizes human tumour cells to radiation

Author： Machida H. Matsumoto Y. Shirai M. Kubota N.

ISSN： 1362-3095

Source： International Journal of Radiation Biology, Vol.79, Iss.12, 2003-12, pp. : 973-980

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Geldanamycin-Induced PCNA Degradation in Isolated Hsp90 Complex from Cancer Cells

By Wang Xing Heuvelman Deborah M. Carroll James A. Dufield Dawn R. Masferrer Jaime L.

Cancer Investigation, Vol. 28, Iss. 6, 2010-06 ,pp. : 635-641

Informa Healthcare

Access to resources Recommend Favorite

Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells

International Journal of Oncology, Vol. 46, Iss. 1, 2015-01 ,pp. : 47-54

Spandidos Publications

Access to resources Recommend Favorite

Effect of HSP90 inhibitor in pheochromocytoma PC12 cells: an experimental investigation

By Zhang Chongyu Xu Yunze Chen Dongning Zhao Juping Shen Zhoujun Wu Yuxuan Zhu Yu

Tumor Biology, Vol. 34, Iss. 6, 2013-12 ,pp. : 4065-4071

Springer Publishing Company

Access to resources Recommend Favorite

Hsp90 inhibitor as a sensitizer of cancer cells to different therapies (Review)

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 907-926

Spandidos Publications

Access to resources Recommend Favorite

The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathway

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 619-624

Spandidos Publications

Access to resources Recommend Favorite